Katie Pope Kopp, 64, of Parkville, Mo., at Union Station in Kansas City this week. Kopp underwent a new form of experimental CAR T-cell therapy that used the CRISPR gene-editing technique to treat her non-Hodgkin lymphoma. The cancer has been in remission for over a year. (Barrett Emke for NPR)